Benzidamina teva - symptomatic treatment sore throat 20 tablets 3 mg

Product Description

Symptomatic treatment of sore throat.

Indications

Benzidamine Teva is indicated for the local symptomatic treatment of acute sore throat in adults and children over 6 years of age.

Composition

Active ingredients

Each lozenge contains 3 mg of benzydamine hydrochloride (equivalent to 2.68 mg of benzydamine).

Excipients

Isomalt (E-953) Citric acid monohydrate Aspartame (E-951) Quinoline yellow (E-104) Honey flavour Orange flavour Peppermint oil Colouring Cochineal red (E-124)

Directions for use and Dosage

Adults and children Children over 6 years: one lozenge 3 times a day.
Do not exceed 7 days of treatment.
In case of symptoms persisting for more than 3 days or high fever, the clinical situation must be evaluated. Paediatric population: Given the type of pharmaceutical form, Benzidamine Teva should not be administered to children under 6 years of age.
Children from 6 to 11 years of age: the product must be taken under the supervision of an adult. For oropharyngeal use: Slowly dissolve one lozenge in the mouth.
Do not swallow.
Do not chew.

Warnings

Benzidamine Teva should not be administered to children under 6 years of age.
The use of benzydamine is not recommended in patients with hypersensitivity to salicylates (e.g., acetylsalicylic acid and salicylic acid) or other NSAIDs.
Administer with caution in subjects who suffer or have suffered in the past from episodes of bronchial asthma, as bronchospasm may occur in these patients.
In a limited number of patients, oropharyngeal ulcerations may be a sign of more serious pathologies. Therefore, if the symptoms worsen, do not improve, or persist for more than three days, or if fever or other symptoms occur, the patient should contact their doctor.
The product contains aspartame, a source of phenylalanine, which may cause allergic reactions. may be harmful in patients with phenylketonuria.
The product contains isomalt, and patients with rare hereditary problems of fructose intolerance should not take this medicine.
This medicine contains "cochineal red", which may cause allergic reactions.

Interactions

No interaction studies have been performed and no clinically relevant interactions with other medicinal products have been reported.

Pregnancy and breastfeeding

There are insufficient data from the use of benzydamine in pregnant and breastfeeding women. Excretion in breast milk has not been studied.
Animal studies are insufficient to highlight the effects on pregnancy and breastfeeding.
The potential risk for humans is unknown.
Benzidamine Teva should not be used during pregnancy and breastfeeding.

Storage

This medicine does not require any special storage conditions.

Format

20 3 mg tablets.